[SLN] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
29-Sep-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -11.92%
YoY- -349.46%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -4,799 -4,799 -5,370 -5,370 -4,894 -4,894 1,441 -
Tax 694 694 507 507 550 550 508 23.19%
NP -4,105 -4,105 -4,862 -4,862 -4,344 -4,344 1,949 -
Tax Rate - - - - - - -35.30% -
Total Cost 4,105 4,105 4,862 4,862 4,344 4,344 -1,949 -
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -0.17 -0.17 -0.21 -0.21 -0.19 -0.19 0.08 -
EPS Diluted -0.17 -0.17 -0.21 -0.21 -0.19 -0.19 0.08 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.